In obesity or insulin-treated type 2 diabetes, the patient suffers from sustained anabolic state driven by the excess of caloric intake or lack of exercise and reinforced by insulin or insulin-enhancing therapies to lower circulating glucose, leading to a loss of metabolic rhythm and metabolic inflexibility [3]. This evidence concerns the gene INS and type 2 diabetes mellitus.